CY1125175T1 - Παραγωγα πολυμυξινης και η χρηση τους σε συνδυασμενη θεραπεια μαζι με διαφορετικα αντιβιοτικα - Google Patents
Παραγωγα πολυμυξινης και η χρηση τους σε συνδυασμενη θεραπεια μαζι με διαφορετικα αντιβιοτικαInfo
- Publication number
- CY1125175T1 CY1125175T1 CY20221100299T CY221100299T CY1125175T1 CY 1125175 T1 CY1125175 T1 CY 1125175T1 CY 20221100299 T CY20221100299 T CY 20221100299T CY 221100299 T CY221100299 T CY 221100299T CY 1125175 T1 CY1125175 T1 CY 1125175T1
- Authority
- CY
- Cyprus
- Prior art keywords
- combination therapy
- different antibiotics
- polymyxin derivatives
- iii
- compounds
- Prior art date
Links
- 108010040201 Polymyxins Proteins 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201404301A GB201404301D0 (en) | 2014-03-11 | 2014-03-11 | Compounds and combinations |
| GB201421019A GB201421019D0 (en) | 2014-11-26 | 2014-11-26 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1125175T1 true CY1125175T1 (el) | 2024-12-13 |
Family
ID=52823596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20221100299T CY1125175T1 (el) | 2014-03-11 | 2022-04-20 | Παραγωγα πολυμυξινης και η χρηση τους σε συνδυασμενη θεραπεια μαζι με διαφορετικα αντιβιοτικα |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20170073373A1 (https=) |
| EP (1) | EP3116897B1 (https=) |
| JP (1) | JP6785659B2 (https=) |
| KR (2) | KR20230152779A (https=) |
| CN (1) | CN106232617B (https=) |
| AU (1) | AU2015228898B2 (https=) |
| CA (1) | CA2940455C (https=) |
| CY (1) | CY1125175T1 (https=) |
| DK (1) | DK3116897T3 (https=) |
| ES (1) | ES2910072T3 (https=) |
| HR (1) | HRP20220387T1 (https=) |
| IL (1) | IL247243B (https=) |
| LT (1) | LT3116897T (https=) |
| MX (1) | MX359104B (https=) |
| PL (1) | PL3116897T3 (https=) |
| PT (1) | PT3116897T (https=) |
| RS (1) | RS63138B1 (https=) |
| RU (1) | RU2740190C2 (https=) |
| SI (1) | SI3116897T1 (https=) |
| TW (1) | TWI709575B (https=) |
| WO (1) | WO2015135976A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2855916A1 (en) * | 2011-11-18 | 2013-05-23 | Novacta Biosystems Limited | Polymyxin derivatives |
| JP2017512818A (ja) | 2014-04-01 | 2017-05-25 | モナシュ、ユニバーシティＭｏｎａｓｈ Ｕｎｉｖｅｒｓｉｔｙ | 抗菌性化合物としてのポリミキシン誘導体 |
| US12146004B2 (en) | 2014-11-26 | 2024-11-19 | Spero Therapeutics, Inc. | Polymyxin compounds and uses thereof |
| WO2016100578A2 (en) | 2014-12-16 | 2016-06-23 | Micurx Pharmaceuticals, Inc. | Antimicrobial polymyxins for treatment of bacterial infections |
| CN105030744B (zh) * | 2015-07-09 | 2019-04-19 | 广州英赛特生物技术有限公司 | 取代苯胍衍生物作为多粘菌素类抗生素增效剂的应用 |
| EP3356387B1 (en) * | 2015-09-29 | 2024-06-26 | Monash University | Antimicrobial polymyxin derivative compounds |
| JP6744622B2 (ja) * | 2016-06-16 | 2020-08-19 | 学校法人上智学院 | ピペリジン化合物の製造方法 |
| CN111527100A (zh) * | 2017-11-02 | 2020-08-11 | 昆士兰大学 | 肽类抗生素 |
| RS65128B1 (sr) * | 2018-06-25 | 2024-02-29 | Spero Therapeutics Inc | Jedinjenja |
| CN111690040A (zh) * | 2019-03-12 | 2020-09-22 | 上海来益生物药物研究开发中心有限责任公司 | 多粘菌素衍生物、其制备方法和应用 |
| WO2021150792A1 (en) | 2020-01-21 | 2021-07-29 | Micurx Pharmaceuticals, Inc. | Novel compounds and composition for targeted therapy of kidney-associated cancers |
| WO2022098950A1 (en) | 2020-11-06 | 2022-05-12 | Spero Therapeutics, Inc. | Compounds |
| JP7621502B2 (ja) | 2021-02-02 | 2025-01-24 | コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー | ビフェニル誘導体化合物を有効成分として含有する抗菌補助剤及びこの用途 |
| CN120699105B (zh) * | 2025-08-19 | 2025-11-21 | 中国药科大学 | 一种氘代抗菌肽及其组合物和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060004185A1 (en) * | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
| BRPI0715095B8 (pt) * | 2006-08-11 | 2021-05-25 | Northern Antibiotics Oy | derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i). |
| CA2747995A1 (en) * | 2008-12-23 | 2010-07-01 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| CN101851270A (zh) * | 2009-04-03 | 2010-10-06 | 梁浩 | 一种多粘菌素衍生物及其制备方法 |
| US8415307B1 (en) * | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| WO2012168820A1 (en) * | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| CA2855916A1 (en) * | 2011-11-18 | 2013-05-23 | Novacta Biosystems Limited | Polymyxin derivatives |
| KR102354902B1 (ko) * | 2013-05-22 | 2022-01-24 | 에버레스트 메디신즈 (싱가포르) 피티이. 리미티드 | 폴리믹신 유도체 및 상이한 항생제와의 조합 요법에 있어서의 이들의 용도 |
-
2015
- 2015-03-11 MX MX2016011682A patent/MX359104B/es active IP Right Grant
- 2015-03-11 RU RU2016139978A patent/RU2740190C2/ru active
- 2015-03-11 LT LTEPPCT/EP2015/055046T patent/LT3116897T/lt unknown
- 2015-03-11 SI SI201531832T patent/SI3116897T1/sl unknown
- 2015-03-11 US US15/125,415 patent/US20170073373A1/en not_active Abandoned
- 2015-03-11 WO PCT/EP2015/055046 patent/WO2015135976A1/en not_active Ceased
- 2015-03-11 TW TW104107773A patent/TWI709575B/zh active
- 2015-03-11 KR KR1020237036093A patent/KR20230152779A/ko active Pending
- 2015-03-11 EP EP15715172.1A patent/EP3116897B1/en active Active
- 2015-03-11 ES ES15715172T patent/ES2910072T3/es active Active
- 2015-03-11 HR HRP20220387TT patent/HRP20220387T1/hr unknown
- 2015-03-11 AU AU2015228898A patent/AU2015228898B2/en active Active
- 2015-03-11 DK DK15715172.1T patent/DK3116897T3/da active
- 2015-03-11 KR KR1020167027152A patent/KR20160135739A/ko not_active Ceased
- 2015-03-11 CN CN201580011858.0A patent/CN106232617B/zh active Active
- 2015-03-11 RS RS20220387A patent/RS63138B1/sr unknown
- 2015-03-11 JP JP2016556784A patent/JP6785659B2/ja active Active
- 2015-03-11 PL PL15715172T patent/PL3116897T3/pl unknown
- 2015-03-11 PT PT157151721T patent/PT3116897T/pt unknown
- 2015-03-11 CA CA2940455A patent/CA2940455C/en active Active
-
2016
- 2016-08-11 IL IL247243A patent/IL247243B/en active IP Right Grant
-
2021
- 2021-01-25 US US17/157,393 patent/US20210221848A1/en not_active Abandoned
-
2022
- 2022-04-20 CY CY20221100299T patent/CY1125175T1/el unknown
-
2023
- 2023-03-24 US US18/126,270 patent/US20230322858A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3116897A1 (en) | 2017-01-18 |
| MX2016011682A (es) | 2017-04-27 |
| DK3116897T3 (da) | 2022-03-28 |
| KR20230152779A (ko) | 2023-11-03 |
| LT3116897T (lt) | 2022-05-10 |
| RU2016139978A (ru) | 2018-04-13 |
| HRP20220387T1 (hr) | 2022-05-27 |
| RU2016139978A3 (https=) | 2018-10-17 |
| EP3116897B1 (en) | 2022-03-02 |
| US20230322858A1 (en) | 2023-10-12 |
| PT3116897T (pt) | 2022-04-07 |
| CA2940455C (en) | 2023-03-21 |
| TWI709575B (zh) | 2020-11-11 |
| ES2910072T3 (es) | 2022-05-11 |
| SI3116897T1 (sl) | 2022-06-30 |
| JP2017510570A (ja) | 2017-04-13 |
| RU2740190C2 (ru) | 2021-01-12 |
| TW201617362A (zh) | 2016-05-16 |
| AU2015228898B2 (en) | 2018-11-15 |
| IL247243A0 (en) | 2016-09-29 |
| US20170073373A1 (en) | 2017-03-16 |
| WO2015135976A1 (en) | 2015-09-17 |
| CN106232617A (zh) | 2016-12-14 |
| JP6785659B2 (ja) | 2020-11-18 |
| CN106232617B (zh) | 2022-06-24 |
| KR20160135739A (ko) | 2016-11-28 |
| MX359104B (es) | 2018-09-14 |
| PL3116897T3 (pl) | 2022-05-30 |
| AU2015228898A1 (en) | 2016-10-20 |
| CA2940455A1 (en) | 2015-09-17 |
| US20210221848A1 (en) | 2021-07-22 |
| RS63138B1 (sr) | 2022-05-31 |
| IL247243B (en) | 2020-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125175T1 (el) | Παραγωγα πολυμυξινης και η χρηση τους σε συνδυασμενη θεραπεια μαζι με διαφορετικα αντιβιοτικα | |
| CY1126855T1 (el) | Ενωσεις κυκλικων δινουκλεοτιδιων για τη θεραπευτικη αγωγη καρκινου | |
| CY1123598T1 (el) | Μακροκυκλικα πεπτιδια χρησιμα ως ανοσοδιαμορφωτες | |
| CL2019001874A1 (es) | Inhibidores de tgfß1 isoforma-específicos contexto-permisivos y uso de los mismos. | |
| CY1122065T1 (el) | Ενωσεις αλκυλ-αμιδο-υποκατεστημενου πυριδυλιου χρησιμες ως διαμορφωτες των αποκρισεων il-12, il-23 και/η ιfναλφα | |
| CY1121701T1 (el) | Οργανικες ενωσεις μονοβακταμης για την αντιμετωπιση βακτηριακων λοιμωξεων | |
| HUE057426T2 (hu) | Heteroaril-szubsztituált béta-hidroxietilamin-származékok magas vécukorszint kezelésére való alkalmazásra | |
| CY1121384T1 (el) | Συνδυαστικη θεραπεια για την αγωγη ανθεκτικων βακτηριακων λοιμωξεων | |
| CY1120893T1 (el) | Μεθοδοι για αγωγη μολυνσεων ιου filoviridae | |
| CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
| MX2020002823A (es) | Fluorofenil beta-hidroxietilaminas y su uso en el tratamiento de la hiperglucemia. | |
| GT201500088A (es) | Derivados de 5-fenoxi-3h-pirimidin-4-ona y su uso como inhibidores de la transcriptasa inversa del vih | |
| UY34657A (es) | ?derivados macrocíclicos para el tratamiento de enfermedades?. | |
| CY1122818T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου | |
| UY34278A (es) | Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades | |
| CY1120607T1 (el) | Παραγωγα ισοϊνδολινης για χρηση στη θεραπεια μιας ιικης μολυνσης | |
| MX381911B (es) | Derivados heterociclicos y uso de los mismos. | |
| IL271863B (en) | Compounds and use thereof for the treatment of microbial infections | |
| CL2015003019A1 (es) | Derivados biaromáticos antibacterianos | |
| CY1122923T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
| CY1122882T1 (el) | Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
| MX345351B (es) | Compuesto macrociclico y metodos para su produccion. | |
| BR112017026061A2 (pt) | composto, uso de um composto, e, método de tratamento de uma infecção viral | |
| CY1122892T1 (el) | Παραγωγα 3-(καρβοξυμεθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
| CY1122971T1 (el) | Ενωσεις διυδροπυριμιδιν-2-ονης και ιaτρικη χρηση αυτων |